Liraglutide (known by the brand name Saxenda) and semaglutide (also known as Wegovy and Ozempic) are known as GLP-1 receptor agonists
Saxenda (liraglutide 3.0 mg) is a prescription medicine licensed in the UK for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related health conditions such as type 2 diabetes, hypertension, or dyslipidaemia
Patients who experience steady results may remain more engaged in their overall wellness plan, supporting outcomes that persist beyond initial weight loss phases
They sincerely care about each of their clients and insist on providing the highest possible competence and ethical standards in their representation
White WM, Makin IRS, Barthe PG, Slayton MH, Gliklich RE
Conveniently located in the heart of Houston, we make it easy for you to access this cutting-edge medicine close to home